Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPAR α mice fed an American dietShow others and affiliations
2021 (English)In: Toxicology and Applied Pharmacology, ISSN 0041-008X, E-ISSN 1096-0333, Vol. 426, article id 115644Article in journal (Refereed) Published
Abstract [en]
Per- and polyfluoroalkyl substances (PFAS) are pervasive in the environment resulting in nearly universal detection in people. Human serum PFAS concentrations are strongly associated with increased serum low-density lipoprotein cholesterol (LDL-C), and growing evidence suggests an association with serum triacylglycerides (TG). Here, we tested the hypothesis that perfluorooctanoic acid (PFOA) dysregulates liver and serum triacylglycerides in human peroxisome proliferator activated receptor α (hPPARα)-expressing mice fed an American diet. Mice were exposed to PFOA (3.5 mg/L) in drinking water for 6 weeks resulting in a serum concentration of 48 ± 9 μg/ml. In male and female hPPARα mice, PFOA increased total liver TG and TG substituted with saturated and monounsaturated fatty acids. Lack of expression of PPARα alone also increased total liver TG, and PFOA treatment had little effect on liver TG in PPARα null mice. In hPPARα mice, PFOA neither significantly increased nor decreased serum TG; however, there was a modest increase in TG associated with very low-density cholesterol particles in both sexes. Intriguingly, in female PPARα null mice, PFOA significantly increased serum TG, with a similar trend in males. PFOA also modified fatty acid and TG homeostasis-related gene expression in liver, in a hPPARα-dependent manner, but not in adipose. The results of our study and others reveal the importance of context (serum concentration and genotype) in determining the effect of PFOA on lipid homeostasis.
Place, publisher, year, edition, pages
Academic Press, 2021. Vol. 426, article id 115644
Keywords [en]
Lipid homeostasis, Perfluorooctanoic acid, Peroxisome proliferator activated receptor α, Triacylglyceride
National Category
Environmental Sciences
Identifiers
URN: urn:nbn:se:oru:diva-93497DOI: 10.1016/j.taap.2021.115644ISI: 000681701200005PubMedID: 34252412Scopus ID: 2-s2.0-85110266269OAI: oai:DiVA.org:oru-93497DiVA, id: diva2:1584052
Funder
Swedish Research Council, 201605176Swedish Research Council Formas, 2019-00869Novo Nordisk, 0063971
Note
Funding agencies:
National Institute of Environmental Health Sciences Superfund Research Program P42 ES007381
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Environmental Health Sciences (NIEHS) R01 ES027813
T32 ES01456
2021-08-102021-08-102021-08-23Bibliographically approved